Company Announcements

Total Voting Rights

Source: RNS
RNS Number : 3789X
Croda International PLC
29 April 2019
 

Croda International Plc
(the "Company")

Share Consolidation: Amendment to the Official List, Total Voting Rights and Share Capital

Further to the Company's announcement on 25 April 2019, shareholder approval was granted at the Company's General Meeting on 24 April 2019 to pay a special dividend of 115 pence per share and to undertake an associated share consolidation. The share consolidation became effective at 08.00am UK time this morning.

Admission of New Ordinary Shares

Accordingly, the Company's new ordinary shares of 10.609756 pence each were admitted to the premium listing segment of the Official List and admitted to trading on the London Stock Exchange's main market for listed securities at 08.00am UK time today. The new ordinary shares have an ISIN of GB00BJFFLV09.

Voting Rights and Share Capital

In accordance with DTR 5.6.1A(1), the Company's issued share capital as at 08.00am on 29 April 2019 consisted of 131,906,881 ordinary shares of 10.609756 pence each, of which 3,249,906 shares are held in treasury.

The figure of 128,656,975 ordinary shares may therefore be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

Further details of the share consolidation can be found in the Notice of Meeting published by the Company on 18 March 2019.

Further information

For further information, please contact:

 

 

 

 

Tom Brophy

Group General Counsel & Company Secretary

+44 (0)1405 860551

 

29 April 2019


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRPGUPACUPBUMB